The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030, claims Roots Analysis
Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of viable biological targets have been identified and are being investigated for therapeutic relevance   Roots Analysis has announced the addition of “Soft Tissue Sarcoma: Focus on Angiosarcoma, Chondrosarcoma, and Liposarcoma...
0 Comments 0 Shares
Sponsored